2m 2m 2m 2m 2m 2m 2m
ABCELLERA BIOLOG (ABCL)
NASDAQ
$6.60+$0.08 (+1.15%)
Price as of Jul 14, 2026 6:04 AM EDT- $2.0BMarket Cap
- 53.77%1-Year Change
- BiotechnologyIndustry
ABCELLERA BIOLOG (ABCL)
$6.60+$0.08 (+1.15%)
ABCL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.52 | ||
Change | -$0.28 (-4.12%) | ||
Open | $6.71 | ||
High | $6.76 | ||
Low | $6.40 | ||
Previous Close | $6.80 | ||
Volume | 4,059,690 | ||
30-Day Average Volume | 8,069,580 | ||
1-Week Change | -17.15% | ||
1-Month Change | 24.43% | ||
1-Year Change | 53.77% | ||
3-Year Change | -12.13% | ||
5-Year Change | -63.43% | ||
Fundamentals | |||
Shares Outstanding | 305.4M | ||
Total Assets | $1.3B | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $8.1M | ||
Net Income | -$43.2M | ||
Free Cash Flow | -$37.4M | ||
EBIT | -$49.5M | ||
EBITDA | -$48.6M | ||
Net Working Capital | $617.3M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | 243 | ||
P/B | 2 | ||
P/E | -47 | ||
PEG | 0 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue